Description

Flunixin Meglumine is a non-steroidal anti-inflammatory drug (NSAID) of the nicotinic acid class, formulated as the meglumine salt of flunixin for enhanced solubility. This potent compound is valued for its powerful analgesic, anti-inflammatory, and antipyretic properties, making it a critical therapeutic agent. It is primarily required by the veterinary pharmaceutical industry for the management of pain and inflammation associated with musculoskeletal disorders and colic in large animals, particularly horses and cattle.

Application

• Veterinary Pharmaceutical Formulations: Primary use in injectable solutions for the treatment of pain and inflammation in large animals.
• Equine Medicine: Management of musculoskeletal pain and fever, as well as alleviation of visceral pain associated with colic.
• Bovine Medicine: Treatment of acute inflammation, such as bovine respiratory disease and mastitis.
• Anti-inflammatory Research: Serves as a reference standard or active ingredient in pharmacological research for NSAID efficacy and safety studies.
• Analgesic Preparations: Used in combination therapies for post-operative pain management in veterinary surgery.
• Generic Drug Manufacturing: Sourcing of the active pharmaceutical ingredient (API) for the production of generic veterinary medicinal products.

Basic Information

Product Name	Flunixin Meglumine
CAS No.	38677-85-9
Molecular Formula	C₁₄H₁₁F₃N₂O₂ · C₇H₁₇NO₅
Molecular Weight	492.47 g/mol
Synonyms	Flunixin Meglumine Salt; Flunixin N-Methylglucamine; Sch 14714; 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid compd. with 1-deoxy-1-(methylamino)-D-glucitol; Flunixamine; Flunixin Mono(N-methyl-D-glucamine); Flunixin N-Methyl-D-glucamine; Flunixin Meglumine USP
EINECS	Contact for details

Quality Control

Our Flunixin Meglumine is manufactured and tested to meet high-purity standards suitable for pharmaceutical use. Quality assurance protocols include identity confirmation, purity assay, and control of specific impurities. A comprehensive Certificate of Analysis (COA) is provided with each batch, detailing results against specifications. We adhere to cGMP principles to ensure consistent quality, reliability, and traceability for our B2B partners.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White or almost white crystalline powder
Identification (IR)	Conforms
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 1.5%
Specific Optical Rotation	+28.0° to +32.0° (c=1 in water)

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.